Lipoprotein(a) and Atherosclerotic Cardiovascular Disease, the Impact of Available Lipid-Lowering Medications on Lipoprotein(a): An Update on New Therapies-Reference-Cited by-同舟云学术

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease, the Impact of Available Lipid-Lowering Medications on Lipoprotein(a): An Update on New Therapies

Published:2022-12 Issue: Volume: Page:
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Tsushima Takahiro,Tsushima Yumiko,Sullivan Claire,Hatipoglu Betul^ORCID

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference71 articles.

1. A new serum type system in man-the LP system;Berg;Acta Pathol Microbiol Scand,1963

2. A test in context: lipoprotein(a);Tsimikas;J Am Coll Cardiol,2017

3. The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma;Steyrer;J Clin Invest,1994

4. HEART UK consensus statement on Lipoprotein(a): a call to action;Cegla;Atherosclerosis,2019

5. Lipoprotein(a): resurrected by genetics;Kronenberg;J Intern Med,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of High Lipoprotein(a) Concentration and Risk of Ischaemic Stroke in Atrial Fibrillation Patients;International Journal of General Medicine;2024-05

2. Impact of High Lipoprotein(a) on Long‐Term Survival Following Coronary Artery Bypass Grafting;Journal of the American Heart Association;2024-02-06

3. Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting;Biomedicines;2023-12-12

4. Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents;Biomedicines;2023-06-08